Previous Page  4 / 11 Next Page
Information
Show Menu
Previous Page 4 / 11 Next Page
Page Background

A p r i l 1 8 - 1 9 , 2 0 1 9

P a r i s , F r a n c e

Page 28

Nano Research & Applications

ISSN: 2471-9838

Advanced Nanotechnology 2019

EuroSciCon Conference on

Advanced Nanotechnology

B

acille Calmette-Guerin (BCG) is still the only authenticated vaccine against

tuberculosis. But due to its drawbacks, a need to a new formula has

emerged. Implication of "Nanovaccinology" is one of the possible alternatives.

The non-viral vectors have low transfection ability. In the context, this work

aims to add two adjuvants to calcium phosphate nanoparticles (CPNPs)

functionalized with ESAT-6 cloned pc DNA3.1 (+) plasmid. ESAT-6 gene is

specific to

Mycobacterium tuberculosis complex

(MTC) and encodes a T-cell

antigen. The adjuvants in practice are Herring protamine and CpG-ODN 7909.

Each has different strategies in enhancing the immune response, protamine

is particulate adjuvant while CpG is an immunopotentiator substance.

Nanocomplex was transfected in to after THP-1 monocytic cell line its

activation to macrophage via 100ng/ml PMA. Cellular immune response, IL-12

and TNF-ɑ also ESAT-6 protein production were assayed via Sandwich ELISA

technique. Results revealed that, CPNPs offer only a partial protection to the

adsorbed plasmid against enzymatic degradation. Nanocomplex formula

with two adjuvants resulted in significantly higher cellular immune response

comparing to formula carrying one adjuvant. In conclusion, implication of

CPNPs in gene delivery accompanied with two adjuvants each possess

different strategy will result in partial protection to the delivered gene with

upsurge cellular immune response.

Biography

Dr. Ghassaq AlUbaidi, has completed her PhD in Medical

Microbiology at age of 42, from Dep. of Microbiology/ College

of Medicine/ AL-Nahrain University. The dissertation involved

the application of nanomaterials in pathogens diagnosis and

gene delivery.She has been working a biological researcher

since 2003. Now, she is working as a researcher in the Medical

research unit / College of Medicine/ AL-Nahrain University. She

is a member in the British Society for Immunology (BSI) since

2017. She has published 7 articles in fields of Virology and

nanomaterials. Now, she is actively involved in searching for a

DNA vaccine against

M. tuberculosis

, which represent a serious

health problem in Middle East and African countries.

Ghasaqtariq119@gmail.com

Evaluation of synergistic effect of CpG-ODN-7909 and protamine

on transfection process mediated by calcium phosphate

nanoparticles

Ghassaq T Al Ubaidi

1

, Ahmed A Abbas

1

, Ali A Taha

2

, Qasim S

Sharhan

1

, Israa W Ahmed

1

and Ilham A Jasim

1

1

College of Medicine, Al Nahrain University, Iraq

2

University of Technology, Iraq

Ghassaq T Al Ubaidi et al., Nano Res Appl 2019, Volume:5

DOI: 10.21767/2471-9838-C2-033